Back to search

United States· US:70436-206_09c94d69-7bea-2491-e063-6394a90a6438

sodium nitroprusside in 0.9% sodium chloride

A medicinal product containing sodium nitroprusside, registered in United States by Slate Run Pharmaceuticals, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedsodium nitroprusside in 0.9% sodium c…ATC—REGISTER NO.US:70436-206_09c94d69…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SODIUM NITROPRUSSIDE
Manufacturer
Slate Run Pharmaceuticals, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7043620680
    1 VIAL, SINGLE-DOSE in 1 CARTON (70436-206-80) / 100 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    70436-206-80

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium nitroprusside in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium nitroprusside products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Nipruss, Nitroprussid-Natrium Aftpharm
  • Germany · Nipruss, Nitroprussid-Natrium Aftpharm
  • Denmark · Nipruss
  • Spain · Nitroprussiat Fides
  • Finland · Nipruss
  • United Kingdom (Northern Ireland) · Sodium Nitroprusside Aft Uk
  • Hungary · Nipruss
  • Iceland · Nipruss
  • Netherlands · Nipruss
  • Norway · Nipruss
  • Sweden · Nipruss

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0749ac5-2647-4068-bb84-883f465a41a8
GET /v1/drugs/d0749ac5-2647-4068-bb84-883f465a41a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": ".2",
  "substance": "SODIUM NITROPRUSSIDE",
  "productndc": "70436-206",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA215846",
  "marketing_category": "ANDA"
}

See everything about sodium nitroprusside.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.